These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9168438)

  • 1. c-kit Point mutation in patients with myeloproliferative disorders.
    Kimura A; Nakata Y; Katoh O; Hyodo H
    Leuk Lymphoma; 1997 Apr; 25(3-4):281-7. PubMed ID: 9168438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-kit point mutation of extracellular domain in patients with myeloproliferative disorders.
    Nakata Y; Kimura A; Katoh O; Kawaishi K; Hyodo H; Abe K; Kuramoto A; Satow Y
    Br J Haematol; 1995 Nov; 91(3):661-3. PubMed ID: 8555071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
    Siitonen T; Savolainen ER; Koistinen P
    Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tyrosine kinase JAK2V617F mutation in human myeloproliferative disorders].
    Xu YY; Li HM; Li XJ; Yang L; Hu DM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):541-4. PubMed ID: 19549360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
    Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
    Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age.
    Kaushansky K
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):5-12. PubMed ID: 17336249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
    Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
    Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].
    Zhang SJ; Li WD; Song JH; Xu W; Qiu HX; Li JY
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2109-12. PubMed ID: 17988529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance.
    Ouerhani S; Gharbi H; Menif S; Safra I; Douzi K; Abbes S
    Cancer Genet; 2012 Sep; 205(9):436-41. PubMed ID: 22939396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis.
    Cairoli R; Grillo G; Beghini A; Cornacchini G; Larizza L; Morra E
    Hematol J; 2004; 5(3):273-5. PubMed ID: 15167915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in the first Ig-like domain of Kit leads to JAK2 activation and myeloproliferation in mice.
    Huang Z; Ruan HB; Zhang ZD; Chen W; Lin Z; Zeng H; Gao X
    Am J Pathol; 2014 Jan; 184(1):122-32. PubMed ID: 24211109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease.
    Ma P; Mali RS; Martin H; Ramdas B; Sims E; Kapur R
    Leukemia; 2012 Jul; 26(7):1499-1506. PubMed ID: 22297723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor and chronic myeloid leukemia CD34+ cells.
    Moore S; McDiarmid LA; Hughes TP
    Leuk Lymphoma; 2000 Jul; 38(3-4):211-20. PubMed ID: 10830729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
    Baxter EJ; Scott LM; Campbell PJ; East C; Fourouclas N; Swanton S; Vassiliou GS; Bench AJ; Boyd EM; Curtin N; Scott MA; Erber WN; Green AR;
    Lancet; 2005 Mar 19-25; 365(9464):1054-61. PubMed ID: 15781101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.